Keyword: PhRMA

While the launch prices of traditional and specialty drugs approved by the Food and Drug Administration doubled in the past 20 years, the rise in the prices of the orphan drug has reached heights that put it in a stratosphere all its own, according to a new report.

Lawmakers who created the modern generics industry never imagined brand-pharma companies maximizing profits by appearing to compete with themselves.

A new bill heading to the California Senate takes aim at pharmaceutical "pay-for-delay" deals.

A Senate committee advanced a major legislative package to tackle high drug prices.

The White House is weighing an executive order that could significantly cut drug prices in Medicare. 

The Trump administration’s plan to end legal protections for drug rebates would boost Part D premiums and federal spending, according to CBO. 

Executives at five pharmacy benefit managers (PBMs) are confirmed for an April hearing on drug prices, plus more insurance headlines.

Anthem Blue Cross Blue Shield Indiana launched a partnership to provide Medicaid beneficiaries free legal assistance, plus more payer news.

HHS Secretary Alex Azar is challenging Congress to take up the administration’s plan to end safe harbor protections for drug rebates. 

CareFirst is donating $1.5 million to charities that assist federal workers affected by the government shutdown, plus more insurance headlines.